Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Esophageal Squamous Cell Carcinoma × Albumin-Bound Paclitaxel × 30 days × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Breast Neoplasms 4 Neoplasm Metastasis 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Pancreatic Ductal 2 Recurrence 1 Oropharyngeal Neoplasms 1 Non-Small Cell Lung Cancer Metastatic 1 Non Small Cell Lung Cancer NSCLC 1 Neoplasms 1 Mouth Neoplasms 1 Metastatic Adenocarcinoma of the Pancreas 1 Lip Neoplasms 1 Laryngeal Neoplasms 1 Gastric Adenocarcinoma 1 Gallbladder Neoplasms 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Squamous Cell 1 Carcinoma 1 Biliary Tract Neoplasms 1 Anus Neoplasms 1

Interventions

pembrolizumab 7 Cisplatin 6 Paclitaxel 5 Drug Therapy 3 toripalimab 2 Radiotherapy 2 Irinotecan 2 Fluorouracil 2 Carboplatin 2 tislelizumab 1 regorafenib 1 osimertinib 1 nimotuzumab 1 lenvatinib 1 aflibercept 1 Oxaliplatin 1 Nivolumab 1 NEO212 1 Levoleucovorin 1 Leucovorin 1 Ipilimumab 1 IFL protocol 1 Histamine H2 Antagonists 1 Histamine Antagonists 1 Fulvestrant 1 Docetaxel 1 Dexamethasone 1 Chemoradiotherapy 1 Bevacizumab 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡